Openclinica | Jotup

Are You Ready for EHR eSource in Clinical Trials? Lessons From the Field, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, April 17, 2024

Openclinica, Organization, UCSD, Health informatics, EHR, MD, EDC, Medicine, Entrepreneurship, Health information management, Cal Collins, FACP, Division, Knowledge

TORONTO, April 17, 2024 /PRNewswire-PRWeb/ -- In this webinar, the expert panel will present and discuss their real-world experiences in electronic health records (EHR) to electronic data capture (EDC) eSource integration in large-scale clinical trials. The attendees will gain insights into the modalities and realities of eSource, its impact on trial speed and accuracy and how to assess and ensure site and stakeholder readiness.

Key Points:

In this free webinar, learn from real-world trials to understand the practical implications, benefits and challenges of eSource integration.
The featured speakers will share essential criteria for evaluating readiness across technology, skills and training and data and standards mapping.
Attendees will also explore how scaling eSource impacts trial efficiency and accuracy, positioning organizations at the forefront of clinical research excellence.
This webinar will help attendees acquire knowledge and tools needed to embrace eSource integration with confidence.

USA Patient Registry Software Market Outlook to 2028, Featuring IQVIA, Optum (UnitedHealth Group), Phytel, Dacima Software, FIGmd, Syapse and Pharos Innovations - ResearchAndMarkets.com

Retrieved on:

Tuesday, March 19, 2024

Oncology, Research, Software, University, Infectious Diseases, Education, Hospitals, Health Technology, Genetics, Health Insurance, Data Management, Science, Technology, Clinical Trials, Biotechnology, FDA, Insurance, Health, Professional Services, IOT (Internet of Things), Data Analytics, White House, Federal Government, Practice Management, Managed Care, Other Health, Public Policy, Government, Pharmaceutical, Other Science, Pancreatic disease, Consolidated, Patient, Conditional sentence, Optum, Health information management, Food and Drug Administration, Geography, NPF, RWE, Internet of things, Openclinica, DNA, Policy, Electronic health record, NIH, City, Privacy, CMS, Food, Organization, Prevalence, Federation, Internet, Cancer, Drug development, IQVIA, Evidence-based medicine, RDCRN, Type, Data science, Caregiver, Public health surveillance, Government agency, Registry, EHR, CDC, National Institutes of Health, Bangladesh Technical Education Board, Medicare, Collection, Medical device

The patient registry market in the US involves the collection, management & analysis of data related to patients with specific medical conditions & diseases.

Key Points:

The patient registry market in the US involves the collection, management & analysis of data related to patients with specific medical conditions & diseases.
Patient registry software could facilitate data sharing and analysis among these entities, leading to increased adoption
The patient registry software market in the USA is a part of the broader healthcare information technology sector.
Key players in the USA patient registry software market includes IQVIA, Dacima Software, OpenClinica, FIGmd, Dendrite Clinical Systems and various universities conducting medical clinical studies.
As technology & data science continue to evolve, the patient registry software market is likely to incorporate more advanced analytics techniques.

A Step-by-Step Approach to EHR eSource in Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, October 11, 2023

EDC, EHR, ESourcing Capability Model, Risk, ROI, Roger Hawkins (drummer), Acquisition, Openclinica, Clinical trial, Cal Collins, Map, Management, Pharmaceutical industry, Cryptocurrency

TORONTO, Oct. 11, 2023 /PRNewswire-PRWeb/ -- The shift from manual data entry of medical records to the automatic acquisition of data from multiple real-world sources is no longer a 'nice to have' in clinical trials. In our post-pandemic landscape, sponsors embracing EHR eSource realize key competitive advantages:

Key Points:

In this free webinar, learn how to adopt an incremental approach to eSource (EHR to EDC integration) across multiple trial scenarios to overcome real and perceived challenges.
Attendees will learn how a strategic approach to EHR eSource today builds a strong competitive advantage.
In our post-pandemic landscape, sponsors embracing EHR eSource realize key competitive advantages:
"EHR eSource represents a revolutionary advancement for clinical trial stakeholders," said Cal Collins, OpenClinica CEO.
"EHR eSource represents a revolutionary advancement for clinical trial stakeholders," said Cal Collins, OpenClinica CEO.

OpenClinica Strengthens Commitment to eSource and SMART on FHIR

Retrieved on:

Wednesday, September 20, 2023

NEEDHAM, Mass., Sept. 20, 2023 /PRNewswire-PRWeb/ -- OpenClinica announced today the company joined the Society for Clinical Data Management (SCDM) eSource Implementation Consortium Taskforce. Additionally, CEO Cal Collins will lead an educational session at the SCDM Annual Conference, October 8-11, 2023, in San Diego. Collins, a steering committee member of Vulcan, one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators, is chairing the SCDM 2023 session, Are you ready for EHR eSource? Lessons from the field, October 11, 9:00-10:00 am Pacific. In the October 11 session, Collins and panelists will discuss experiences, strategies, and proven tactics around the successful adoption and scaling of eSource integration at clinical trial sites from multiple perspectives, with a focus on EHR-to-EDC.

Key Points:

Collins, a steering committee member of Vulcan , one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators , is chairing the SCDM 2023 session, Are you ready for EHR eSource?
OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins.
"OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins, OpenClinica CEO.
OpenClinica and Collins have created eSource and SMART on FHIR educational resources, including:
An interview with Applied Clinical Trials, which can be viewed at: https://www.appliedclinicaltrialsonline.com/view/cal-collins-discusses-t... .

OpenClinica Bolsters Decentralized Clinical Trials Toolkit

Retrieved on:

Thursday, September 7, 2023

Disruptor (video game), Clinical trial, Blog, DCT, Electronic health record, Openclinica, Acquisition, Patient, EHR, Rare, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, EDC, Medical imaging, Pharmaceutical industry

NEEDHAM, Mass., September 7th, 2023 /PRNewswire-PRWeb/ -- OpenClinica debuts eConsent, a complete digital consent solution for improved efficiency, access and patient engagement in clinical trials. OpenClinica Consent is an important addition to the company's decentralized clinical trials (DCT) toolkit, which also includes:

Key Points:

OpenClinica's DCT toolkit improves patient engagement, access and diversity
NEEDHAM, Mass., September 7th, 2023 /PRNewswire-PRWeb/ -- OpenClinica debuts eConsent , a complete digital consent solution for improved efficiency, access and patient engagement in clinical trials.
OpenClinica Consent is an important addition to the company's decentralized clinical trials (DCT) toolkit, which also includes:
OpenClinica UniteTM, an award-winning EHR to EDC integration technology that automates source data acquisition from EHRs and EMRs to clinical trial research databases (EDCs) and case report forms (eCRFs) at scale.
"At OpenClinica, we have long been committed to helping sites and sponsors improve patient participation, engagement and diversity in clinical trials," said Ben Baumann, OpenClinica Co-Founder and Chief Operating Officer.
In May 2023, the U.S. Food and Drug Administration released new draft guidance to advance decentralized clinical trials.

OpenClinica CEO Cal Collins Chosen to Present at DIA 2023

Retrieved on:

Tuesday, June 6, 2023

WALTHAM, Mass., June 6, 2023 /PRNewswire-PRWeb/ -- OpenClinica proudly announces CEO Cal Collins is speaking at the DIA 2023 Global Annual Meeting in Boston, MA, June 25-29. Collins, a steering committee member of the Vulcan Program, Health Level Seven's (HL7) newest Fast Healthcare Interoperability (FHIR) Accelerator, will discuss how SMART on FHIR is the key to unlocking real-world data. His session, SMART on FHIR: Integrating Electronic Health Records as Real-World Data, also includes:

Key Points:

WALTHAM, Mass., June 6, 2023 /PRNewswire-PRWeb/ -- OpenClinica proudly announces CEO Cal Collins is speaking at the DIA 2023 Global Annual Meeting in Boston, MA, June 25-29.
DIA 2023 is the largest global multidisciplinary event for life sciences professionals.
For more information about Collins' DIA 2023 Session, June 27, 4:00 – 5:00 pm, click here .
To schedule a time to discuss SMART on FHIR with Collins and the OpenClinica team, visit: https://www.openclinica.com/contact-us/

Opening the Digital Front Door in Clinical Trials to Improve Patient and Clinician Satisfaction, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, March 22, 2023

Aros, CHRC, SDV, MS, Openclinica, Division, Frustration, Astute, ChromeOS, Pharmaceutical industry

TORONTO, Ontario, Canada, March 22, 2023 /PRNewswire-PRWeb/ -- It's no secret that we live in a digital age, and the key to successful patient engagement and clinician satisfaction is technology. From both perspectives, people want to interact in clinical trials with the same ease and ownership they enjoy with banking, shopping and ordering lunch.

Key Points:

In this free webinar, learn about the challenges, problems and opportunities related to the digital front door in clinical trials and how to overcome them.
The featured speakers will discuss the fiscal and outcome benefits of digital-first strategies in clinical trials.
A digital front door enables sponsors, CROs and AROs to improve patient and clinician satisfaction, data quality and control costs.
Featured speakers will discuss challenges, risks and opportunities in digital front door strategies for traditional, decentralized and hybrid trials.

OpenClinica Maintains Effective Security Controls According to SOC 2 Report

Retrieved on:

Monday, March 6, 2023

SOC, SOC 2, Clinical trial, Openclinica, System and Organization Controls, Privacy, AICPA, American Institute, Confidentiality, CPA, Audit

WALTHAM, Mass., March 6, 2023 /PRNewswire-PRWeb/ -- Today, OpenClinica announced the company successfully completed a System and Organization Controls (SOC) 2 examination. The examination and audit was carried out by an independent third-party CPA firm and underscores OpenClinica's ongoing commitment to effective controls over the security, availability, processing integrity, confidentiality and privacy of its electronic data capture platform. A SOC 2 report is designed to meet the needs of existing or potential customers seeking assurance about the effectiveness of controls used by the service organization to process customer information.

Key Points:

WALTHAM, Mass., March 6, 2023 /PRNewswire-PRWeb/ -- Today, OpenClinica announced the company successfully completed a System and Organization Controls (SOC) 2 examination.
The examination and audit was carried out by an independent third-party CPA firm and underscores OpenClinica's ongoing commitment to effective controls over the security, availability, processing integrity, confidentiality and privacy of its electronic data capture platform.
A SOC 2 report is designed to meet the needs of existing or potential customers seeking assurance about the effectiveness of controls used by the service organization to process customer information.
Current and prospective customers interested in a copy of the SOC 2 report may contact Laura Keita, Senior Director, Compliance at [email protected] .

Thompson Street Capital Partners Completes Growth Investment in OpenClinica

Retrieved on:

Tuesday, February 21, 2023

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today a growth investment in OpenClinica, a cloud-first, unified eClinical platform that accelerates clinical research by allowing users to automatically capture data from Electronic Health Records (EHRs) while integrating with existing clinical workflows.

Key Points:

Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today a growth investment in OpenClinica, a cloud-first, unified eClinical platform that accelerates clinical research by allowing users to automatically capture data from Electronic Health Records (EHRs) while integrating with existing clinical workflows.
Headquartered in Waltham, MA, OpenClinica transforms healthcare through innovative cloud technology that simplifies running clinical trials.
For more than 15 years, OpenClinica has been a leading provider of electronic data capture (EDC), eSource, eCOA/ePRO, randomization, RWD integrations, and analytics and reporting solutions.
“Thompson Street Capital Partners and OpenClinica are united around a shared vision for overcoming the challenges of data collection and enabling more efficient clinical research through data management and automation,” said Cal Collins, Co-Founder and CEO of OpenClinica.

The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%

Retrieved on:

Thursday, February 9, 2023

Software as a service, Veeva Systems, IBM, Hospital, Openclinica, II, Pulse, III, Drug development, Clinical data management, Dassault Group, Oracle Corporation, Merative, USD, Growth, Parexel, Pharmaceutical industry

NEW YORK, Feb. 9, 2023 /PRNewswire/ -- The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%.

Key Points:

NEW YORK, Feb. 9, 2023 /PRNewswire/ -- The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%.
Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) models.
In 2021, the web-hosted segment accounted for the largest share (55.1%) of the global eClinical solutions market.
The pharmaceutical & biopharmaceutical companies segment accounted for the largest share of 38.5% of the global eClinical solutions market, by end user, in 2021.